Novavax Aktie
7,32
EUR
+0,05
EUR
+0,74
%
8,43
USD
+0,05
USD
+0,60
%
Novavax jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 11/2024)
Es gab keine Analysen zu dieser Aktie in den letzten sechs Monaten.
Werbung
Kursziele im Branchenvergleich
| Aktie | Buy | Hold | Sell | Ø Kursziel | Abst. Kursziel |
|---|---|---|---|---|---|
| AstraZeneca PLC | 6 | 1 | 1 | 144,80 GBP | +15,42% |
| Bayer | 2 | 7 | 0 | 26,81 EUR | +0,02% |
| BioNTech (ADRs) | 4 | 2 | 0 | 135,33 USD | +29,29% |
| CanSino Biologics Inc. Registered Shs -A- | 0 | 0 | 0 | - | - |
| CureVac | 0 | 1 | 0 | - | - |
| Fresenius Medical Care (FMC) St. | 3 | 4 | 3 | 47,89 EUR | +2,75% |
| Fresenius SE & Co. KGaA (St.) | 8 | 2 | 0 | 50,73 EUR | +0,54% |
| Gilead Sciences Inc. | 0 | 0 | 0 | - | - |
| Inovio Pharmaceuticals Inc | 0 | 0 | 0 | - | - |
| Johnson & Johnson | 0 | 0 | 0 | - | - |
| Moderna Inc | 0 | 1 | 0 | 42,00 USD | +49,25% |
| Novartis AG | 3 | 4 | 2 | 99,50 CHF | +0,63% |
| Novavax Inc. | 0 | 0 | 0 | - | - |
| Pfizer Inc. | 3 | 4 | 0 | 29,33 USD | +20,75% |
| Roche AG (Genussschein) | 3 | 1 | 4 | 267,71 CHF | +2,30% |
| Sanofi S.A. | 8 | 1 | 0 | 107,38 EUR | +21,64% |
| Sinopharm Group Co Ltd (H) | 0 | 0 | 0 | - | - |
| Valneva | 0 | 0 | 0 | - | - |